{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-146203","form_type":"8-K","ticker":"TCRX","cik":"0001783328","company_name":"TScan Therapeutics, Inc.","filed_at":"2023-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.550816+00:00","generated_at":"2026-06-14T23:55:15.259446+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"TScan enters ATM equity offering with Wedbush, up to 2% commission","bullets":["Entered Sales Agreement with Wedbush Securities for at-the-market issuance of common stock.","Commission of up to 2.0% of gross proceeds; Company sets sale parameters.","Shelf registration statement (333-268260) declared effective May 16, 2023; prospectus supplement filed.","No obligation to sell; either party may suspend or terminate offering on notice.","Sales may also be made to Wedbush as principal at agreed prices; customary indemnification."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-146203","json":"https://secwatch.observer/filing/0001193125-23-146203.json","markdown":"https://secwatch.observer/filing/0001193125-23-146203.md","text":"https://secwatch.observer/filing/0001193125-23-146203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783328/000119312523146203/0001193125-23-146203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783328/000119312523146203/d502216d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T23:55:15.259446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}